Madrigal will study SYH2086 in combination with Rezdiffra for metabolic dysfunction-associated steatohepatitis, aiming for ...

Madrigal Pharmaceuticals ( NASDAQ: MDGL) said it has signed a global licensing deal with CSPC Pharmaceutical for SYH2086, a ...

IISR Surya is a high-yielding turmeric variety developed by ICAR-IISR, Kozhikode. With light-colored rhizomes ideal for ...

Immediate support for the Nifty is seen in 24882. On the upside, unless 25255 is taken out decisively, traders should take a ...

Stock market close highlights on Wednesday, July 23, 2025: In the broader markets, the Nifty MidCap 100 closed with gains of 0.34 per cent, while the Nifty SmallCap 100 ended flat ...

Ahmedabad: CORONA Remedies today announced the acquisition of seven brands from the pharmaceutical division of Bayer in India. Effective July 16, 2025, the acquisition encompasses several brands ...

The FDA notified the Company on June 13, 2025, that the previously disclosed June 17, 2025 PDUFA goal date will not be met due to heavy workload and limited resources.

Fintel reports that on June 6, 2025, Goldman Sachs initiated coverage of Teva Pharmaceutical Industries Limited - Depositary Receipt () (NYSE:TEVA) with a Buy recommendation. Analyst Price ...

Teva Pharmaceutical Industries Limited (NYSE: TEVA) announced today that its investigational drug TEV-53408 has received Fast Track designation from the US Food and Drug Administration (FDA) for ...